Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.950
-0.060 (-1.20%)
At close: May 12, 2025, 4:00 PM
4.960
+0.010 (0.20%)
After-hours: May 12, 2025, 7:58 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $792.77 million as of May 12, 2025. Its market cap has increased by 203.83% in one year.
Market Cap
792.77M
Enterprise Value
1.00B
1-Year Change
203.83%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $792.77M, an increase of 168.03%. That is a compound annual growth rate of 31.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 802.38M | 58.77% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |